Atlas Trials

O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma

Clinical trial NCT00004892 · COMPLETED

Trial details

NCT number
NCT00004892
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Brain and Central Nervous System Tumors
Start date
2000-04-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.